Scott M. Thompson

12.4k total citations · 3 hit papers
117 papers, 9.3k citations indexed

About

Scott M. Thompson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Scott M. Thompson has authored 117 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Cellular and Molecular Neuroscience, 38 papers in Molecular Biology and 35 papers in Cognitive Neuroscience. Recurrent topics in Scott M. Thompson's work include Neuroscience and Neuropharmacology Research (80 papers), Memory and Neural Mechanisms (23 papers) and Tryptophan and brain disorders (19 papers). Scott M. Thompson is often cited by papers focused on Neuroscience and Neuropharmacology Research (80 papers), Memory and Neural Mechanisms (23 papers) and Tryptophan and brain disorders (19 papers). Scott M. Thompson collaborates with scholars based in United States, Switzerland and France. Scott M. Thompson's co-authors include B.H. Gähwiler, Dominique Debanne, Beat H. Gähwiler, Mark D. Kvarta, Nathalie C. Guérineau, Todd D. Gould, Xiang Cai, Tara A. LeGates, H. L. Haas and Carlos A. Zarate and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Scott M. Thompson

115 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

2016 1.1k citations Panos Zanos, Polymnia Georgiou et al. profile →
Paired‐pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release.

1996 520 citations Scott M. Thompson et al. profile →
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

2021 254 citations Andreas B. Wulff, Scott M. Thompson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott M. Thompson United States	54	6.2k	2.8k	2.7k	1.7k	1.6k	117	9.3k
Trevor Sharp United Kingdom	68	11.4k 1.8×	5.5k 2.0×	3.0k 1.1×	1.9k 1.1×	1.1k 0.7×	264	16.2k
Bita Moghaddam United States	67	11.4k 1.8×	5.2k 1.8×	5.6k 2.0×	2.2k 1.3×	2.6k 1.6×	146	16.8k
Anissa Abi‐Dargham United States	73	9.9k 1.6×	4.1k 1.5×	6.3k 2.3×	2.5k 1.5×	2.4k 1.5×	228	19.2k
Gavin P. Reynolds United Kingdom	72	7.7k 1.2×	5.0k 1.8×	2.4k 0.9×	1.5k 0.9×	2.1k 1.3×	329	16.7k
Bryan K. Yamamoto United States	52	5.8k 0.9×	2.3k 0.8×	883 0.3×	1.1k 0.6×	871 0.5×	148	8.7k
Graeme F. Mason United States	64	5.0k 0.8×	3.0k 1.1×	2.5k 0.9×	1.3k 0.8×	1.7k 1.0×	141	12.7k
Patric K. Stanton United States	48	4.8k 0.8×	2.8k 1.0×	2.2k 0.8×	597 0.4×	484 0.3×	126	6.9k
Steven Mennerick United States	54	6.1k 1.0×	4.5k 1.6×	1.7k 0.6×	692 0.4×	643 0.4×	187	10.3k
Francesc Artigas Spain	66	9.5k 1.5×	4.6k 1.7×	2.6k 0.9×	3.5k 2.1×	1.9k 1.2×	276	14.5k
Jeffrey H. Meyer Canada	50	3.5k 0.6×	1.6k 0.6×	1.8k 0.7×	2.1k 1.2×	2.4k 1.5×	153	9.9k

Countries citing papers authored by Scott M. Thompson

Since Specialization

Citations

This map shows the geographic impact of Scott M. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Thompson more than expected).

Fields of papers citing papers by Scott M. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Thompson. The network helps show where Scott M. Thompson may publish in the future.

Co-authorship network of co-authors of Scott M. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Thompson. A scholar is included among the top collaborators of Scott M. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Thompson. Scott M. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Connell, Casey L., et al.. (2025). Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. ACS Pharmacology & Translational Science. 8(11). 3923–3931. 1 indexed citations

Riggs, Lace M., et al.. (2025). Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model. Cell Reports. 44(6). 115743–115743.

Page, Chloe E., C. Neill Epperson, Andrew M. Novick, Korrina A. Duffy, & Scott M. Thompson. (2024). Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Molecular Psychiatry. 29(12). 3802–3813. 19 indexed citations

Riggs, Lace M., Edna F. R. Pereira, Scott M. Thompson, & Todd D. Gould. (2023). cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission. Journal of Neurophysiology. 131(1). 64–74. 8 indexed citations

Thompson, Scott M.. (2023). Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future. Neuropsychopharmacology. 49(1). 83–95. 45 indexed citations

Wulff, Andreas B., Charles D. Nichols, & Scott M. Thompson. (2023). Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. Neuropharmacology. 231. 109504–109504. 19 indexed citations

Fox, Megan E., Andreas B. Wulff, Eric Y. Choi, et al.. (2022). Adaptations in Nucleus Accumbens Neuron Subtypes Mediate Negative Affective Behaviors in Fentanyl Abstinence. Biological Psychiatry. 93(6). 489–501. 17 indexed citations

Riggs, Lace M., Scott M. Thompson, & Todd D. Gould. (2022). (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity. Neuropharmacology. 214. 109153–109153. 8 indexed citations

Tang, Ai‐Hui, et al.. (2021). Subsynaptic positioning of AMPARs by LRRTM2 controls synaptic strength. Science Advances. 7(34). 56 indexed citations

10.

Riggs, Lace M., Yasco Aracava, Panos Zanos, et al.. (2019). (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism. Neuropsychopharmacology. 45(2). 426–436. 42 indexed citations

11.

Morrison, Kathleen E., et al.. (2019). Brexanolone for the treatment of patients with postpartumdepression. Drugs of today. 55(9). 537–537. 2 indexed citations

12.

Zanos, Panos, Scott M. Thompson, Ronald S. Duman, Carlos A. Zarate, & Todd D. Gould. (2018). Convergent Mechanisms Underlying Rapid Antidepressant Action. CNS Drugs. 32(3). 197–227. 125 indexed citations

13.

Zanos, Panos, Jaclyn N. Highland, Samuel R. Krimmel, et al.. (2017). A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice. eNeuro. 4(1). ENEURO.0285–16.2017. 88 indexed citations

14.

Doyle, D. John, Hannah Copeland, Donna M. Bush, L. A. R. Stein, & Scott M. Thompson. (2010). A course for nurses to handle difficult communication situations. A randomized controlled trial of impact on self-efficacy and performance. Patient Education and Counseling. 82(1). 100–109. 62 indexed citations

15.

Misonou, Hiroaki, Scott M. Thompson, & Xiang Cai. (2008). Dynamic Regulation of the Kv2.1 Voltage-Gated Potassium Channel during Brain Ischemia through Neuroglial Interaction. Journal of Neuroscience. 28(34). 8529–8538. 60 indexed citations

16.

Schwarz, Jaclyn M., Shuling Liang, Scott M. Thompson, & Margaret M. McCarthy. (2008). Estradiol Induces Hypothalamic Dendritic Spines by Enhancing Glutamate Release: A Mechanism for Organizational Sex Differences. Neuron. 58(4). 584–598. 112 indexed citations

17.

Gober, Michael D., et al.. (2006). The growth compromised HSV-2 mutant ΔRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures. Brain Research. 1119(1). 26–39. 17 indexed citations

18.

Kao, Joseph P. Y., et al.. (2005). Long-term potentiation of exogenous glutamate responses at single dendritic spines. Proceedings of the National Academy of Sciences. 102(40). 14434–14439. 128 indexed citations

19.

Hilton, Genell, Linda L. Bambrick, Scott M. Thompson, & Margaret M. McCarthy. (2005). Estradiol Modulation of Kainic Acid-Induced Calcium Elevation in Neonatal Hippocampal Neurons. Endocrinology. 147(3). 1246–1255. 19 indexed citations

20.

Thompson, Scott M.. (2000). Cognition. American Journal of Psychiatry. 157(4). 492–492. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact